COVID-19 Updates
Latest News
Seven legal risks of promoting unproven COVID-19 treatments
Depending on the facts, a physician or other health care professional could be charged with reckless endangerment, criminal negligence, or...
From the Journals
No serious CV risks for elderly after Pfizer COVID-19 vaccine
A French study adds to other evidence that the Pfizer mRNA COVID-19 vaccine does not increase the risk for serious cardiovascular adverse events...
Latest News
COVID-19 antibody drug likely works against Omicron, companies say
The preliminary findings haven’t yet been peer-reviewed.
Feature
Ten changes that could keep clinicians in the workforce in a pandemic
Doctors make checklist of low-cost action items to start addressing a wave of providers leaving medicine.
Latest News
Second U.S. COVID-19 case caused by Omicron found
“This news is concerning, but it is not a surprise.”
Latest News
Rapid COVID-19 tests will soon be covered by insurance
The measures are part of a suite of new actions President Joe Biden is expected to announce later today, Dec. 2, in the wake of the arrival of the...
Latest News
First Omicron variant case identified in U.S.
“All close contacts have been contacted and have tested negative.”
Latest News
Moderna warns of material drop in vaccine efficacy against Omicron
“There is no world, I think, where [the effectiveness] is the same level … we had with Delta.”
Latest News
Fauci: Omicron ‘very different from other variants’
“Although partial immune escape may occur, vaccines, particularly boosters, give a level of antibodies that even with variants like Delta give you...
News
FDA panel backs first pill for COVID-19 by a small margin
If authorized by the agency, molnupiravir would be first antiviral agent available as a pill to treat COVID-19.
Latest News
Merck’s COVID-19 pill may be less effective than first hoped
The new results seem to put molnupiravir far below the effectiveness of existing treatments.